Skip to content
Open in App
WuXi XDC Cayman logo

WuXi XDC Cayman

web2

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, developme...

Symbol · 2268
Company profile

About

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services. Additionally, the company engages in the research and development, manufacturing, and marketing of anti-tumor drugs. WuXi XDC Cayman Inc. has a strategic collaboration with Earendil Labs; and Akari Therapeutics. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeHong KongPrimary symbol: 2268
Expert coverage

1 expert evaluated WuXi XDC Cayman.

Orbitrum research

Experts evaluating WuXi XDC Cayman

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment